Who invested in NextPoint Therapeutics?
NextPoint Therapeutics's investors include Invus, Catalio Capital Management and Sanofi.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$76Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $34M sold, first sale Jul 2026
Source recordedSEC filing: $42M sold, first sale Jan 2024
From NextPoint Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
NextPoint Therapeutics's investors include Invus, Catalio Capital Management and Sanofi.
NextPoint Therapeutics has raised $76M across 2 rounds since 2024.
NextPoint Therapeutics's most recent round, $34M, was in Jul 2026.
NextPoint Therapeutics's largest round on record is $43M (Series B), in Feb 2024.
NextPoint Therapeutics's first round on record, in Feb 2024, was backed by Invus, Catalio Capital Management and Sanofi.
NextPoint Therapeutics's latest named round is a Series B, in Feb 2024.
NextPoint Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.